Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer

Planta Medica

Volumn 76, Issue 11, 2010, Pages 1044-1063

  Prasad, Sahdeo ^a   Phromnoi, Kannokarn ^a   Yadav, Vivek R ^a   Chaturvedi, Madan M ^a   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

cancer; flavonoids; fruits; inflammation; NF B; vegetables

Indexed keywords

AGLYCONE; ANTHOCYANIN; BAICALEIN; CATECHIN; CHALCONE DERIVATIVE; CYANIDIN 3 GLUCOSIDE; DAIDZEIN; DIOSMIN; ERIODICTYOL; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOL DERIVATIVE; FLAVOPIRIDOL; FLAVOXATE; GAMMA INTERFERON; GENISTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GREEN TEA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; ISOFLAVONE DERIVATIVE; KAEMPFEROL; NARINGENIN; PROSTATE SPECIFIC ANTIGEN; QUERCETIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RUTOSIDE; SILIBININ; UNINDEXED DRUG;

ANGIOGENESIS; APOPTOSIS; BIOSYNTHESIS; CANCER INVASION; CANCER PREVENTION; CANCER THERAPY; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; DISEASE ASSOCIATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG TOLERABILITY; FRUIT; GENE CONTROL; HUMAN; HYPERBILIRUBINEMIA; INFLAMMATION; LEGUME; LIFESTYLE; METABOLISM; METASTASIS; NONHUMAN; NUT; PROSTATE CANCER; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SPICE; THROMBOEMBOLISM; TUMOR CELL; VEGETABLE;

ANTHOCYANINS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CHEMOKINES; CYTOKINES; FLAVONOIDS; GENE EXPRESSION REGULATION; INFLAMMATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION;

NICOTIANA TABACUM;

EID: 77955081026     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250111     Document Type: Review

References (215)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M J. Cancer statistics, 2009. CA Cancer J Clin 2009 59 225-249
2. Bray F, Moller B. Predicting the future burden of cancer. Nat Rev Cancer 2006 6 63-74
3. Aggarwal B B., Vijayalekshmi R V., Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res 2009 15 425-430
4. Ho R. AANCART comes to Hawaii. Hawaii Med J 2004 63 189-190 193
5. Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappa B by a posttranslational mechanism. Cell 1986 47 921-928
6. Karin M. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol Chem 1999 274 27339-27342
7. Pahl H L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999 18 6853-6866
8. Garg A, Aggarwal B B. Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 2002 16 1053-1068
9. Kumar S, Sharma A, Madan B, Singhal V, Ghosh B. Isoliquiritigenin inhibits IkappaB kinase activity and ROS generation to block TNF-alpha induced expression of cell adhesion molecules on human endothelial cells. Biochem Pharmacol 2007 73 1602-1612
10. Orlowski R Z., Baldwin Jr A S. NF-kappaB as a therapeutic target in cancer. Trends Mol Med 2002 8 385-389
11. Valen G, Yan Z Q., Hansson G K. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 2001 38 307-314
12. Jones W K., Brown M, Ren X, He S, McGuinness M. NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling? Cardiovasc Toxicol 2003 3 229-254
13. Shoelson S E., Lee J, Yuan M. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 2003 27 (Suppl.3) S49-S52
14. Yang L, Cohn L, Zhang D H., Homer R, Ray A, Ray P. Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation. J Exp Med 1998 188 1739-1750
15. Das J, Chen C H., Yang L, Cohn L, Ray P, Ray A. A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol 2001 2 45-50
16. Gagliardo R, Chanez P, Mathieu M, Bruno A, Costanzo G, Gougat C, Vachier I, Bousquet J, Bonsignore G, Vignola A M. Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma. Am J Respir Crit Care Med 2003 168 1190-1198
17. Roshak A K., Callahan J F., Blake S M. Small-molecule inhibitors of NF-kappaB for the treatment of inflammatory joint disease. Curr Opin Pharmacol 2002 2 316-321
18. Lecleire S, Hassan A, Marion-Letellier R, Antonietti M, Savoye G, Ble-Feysot C, Lerebours E, Ducrott P, Dchelotte P, Coffier M. Combined glutamine and arginine decrease proinflammatory cytokine production by biopsies from Crohn's patients in association with changes in nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways. J Nutr 2008 138 2481-2486
19. Huang C J., Nazarian R, Lee J, Zhao P M., Espinosa-Jeffrey A, de Vellis J. Tumor necrosis factor modulates transcription of myelin basic protein gene through nuclear factor kappa B in a human oligodendroglioma cell line. Int J Dev Neurosci 2002 20 289-296
20. Mattson M P., Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 2001 107 247-254
21. Kaltschmidt B, Uherek M, Volk B, Baeuerle P A., Kaltschmidt C. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci USA 1997 94 2642-2647
22. Burke J R. Targeting I kappa B kinase for the treatment of inflammatory and other disorders. Curr Opin Drug Discov Devel 2003 6 720-728
23. Yamamoto Y, Gaynor R B. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001 107 135-142
24. Gorman P N., Yao P, Seshadri V. Finding the answers in primary care: information seeking by rural and nonrural clinicians. Stud Health Technol Inform 2004 107 1133-1137
25. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001 357 539-545
26. Coussens L M., Werb Z. Inflammation and cancer. Nature 2002 420 860-867
27. Kuper H, Adami H O., Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med 2000 248 171-183
28. Hussain S P., Hofseth L J., Harris C C. Radical causes of cancer. Nat Rev 2003 3 276-285
29. de Visser K E., Eichten A, Coussens L M. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006 6 24-37
30. Castellarin S D., Di Gaspero G. Transcriptional control of anthocyanin biosynthetic genes in extreme phenotypes for berry pigmentation of naturally occurring grapevines. BMC Plant Biol 2007 7 46
31. Robak J, Gryglewski R J. Bioactivity of flavonoids. Pol J Pharmacol 1996 48 555-564
32. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983 32 1141-1148
33. Hrazdina G, Zobel A M., Hoch H C. Biochemical, immunological, and immunocytochemical evidence for the association of chalcone synthase with endoplasmic reticulum membranes. Proc Natl Acad Sci USA 1987 84 8966-8970
34. Ververidis F, Trantas E, Douglas C, Vollmer G, Kretzschmar G, Panopoulos N. Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part II: reconstruction of multienzyme pathways in plants and microbes. Biotechnol J 2007 2 1235-1249
35. Wilmouth R C., Turnbull J J., Welford R W., Clifton I J., Prescott A G., Schofield C J. Structure and mechanism of anthocyanidin synthase from Arabidopsis thaliana. Structure 2002 10 93-103
36. Turnbull W B., Pease A R., Stoddart J F. Toward the synthesis of large oligosaccharide-based dendrimers. Chembiochem 2000 1 70-74
37. Saito K, Kobayashi M, Gong Z, Tanaka Y, Yamazaki M. Direct evidence for anthocyanidin synthase as a 2-oxoglutarate-dependent oxygenase: molecular cloning and functional expression of cDNA from a red forma of Perilla frutescens. Plant J 1999 17 181-189
38. Kitamura S, Shikazono N, Tanaka A. TRANSPARENT TESTA 19 is involved in the accumulation of both anthocyanins and proanthocyanidins in Arabidopsis. Plant J 2004 37 104-114
39. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004 79 727-747
40. Hollman P C., van Trijp J M., Buysman M N., van der Gaag M S., Mengelers M J., de Vries J H., Katan M B. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett 1997 418 152-156
41. Guy L, Vedrine N, Urpi-Sarda M, Gil-Izquierdo A, Al-Maharik N, Boiteux J P., Scalbert A, Rmsy C, Botting N C., Manach C. Orally administered isoflavones are present as glucuronides in the human prostate. Nutr Cancer 2008 60 461-468
42. Dalais F S., Meliala A, Wattanapenpaiboon N, Frydenberg M, Suter D A., Thomson W K., Wahlqvist M L. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer. Urology 2004 64 510-515
43. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 2006 66 1234-1240
44. Flaig T W., Gustafson D L., Su L J., Zirrolli J A., Crighton F, Harrison G S., Pierson A S., Agarwal R, Glod L M. A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. Invest New Drugs 2007 25 139-146
45. Flaig T W., Glode M, Gustafson D, van Bokhoven A, Tao Y, Wilson S, Su L J., Li Y, Harrison G, Agarwal R, Crawford E D., Lucia M S., Pollak M. A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer. The Prostate 2010 70 848-855
46. Felgines C, Texier O, Morand C, Manach C, Scalbert A, Rgerat F, Rmsy C. Bioavailability of the flavanone naringenin and its glycosides in rats. Am J Physiol Gastrointest Liver Physiol 2000 279 G1148-G1154
47. Son T G., Camandola S, Mattson M P. Hormetic dietary phytochemicals. Neuromol Med 2008 10 236-246
48. Utesch D, Feige K, Dasenbrock J, Broschard T H., Harwood M, Danielewska-Nikiel B, Lines T C. Evaluation of the potential in vivo genotoxicity of quercetin. Mutat Res 2008 654 38-44
49. Shen K H., Chang J K., Hsu Y L., Kuo P L. Chalcone arrests cell cycle progression and induces apoptosis through induction of mitochondrial pathway and inhibition of nuclear factor kappa B signalling in human bladder cancer cells. Basic Clin Pharmacol Toxicol 2007 101 254-261
50. Liu Y C., Hsieh C W., Wu C C., Wung B S. Chalcone inhibits the activation of NF-kappaB and STAT3 in endothelial cells via endogenous electrophile. Life Sci 2007 80 1420-1430
51. Abuarqoub H, Foresti R, Green C J., Motterlini R. Heme oxygenase-1 mediates the anti-inflammatory actions of 2-hydroxychalcone in RAW 264.7 murine macrophages. Am J Physiol Cell Physiol 2006 290 C1092-C1099
52. Lee S H., Seo G S., Kim J Y., Jin X Y., Kim H D., Sohn D H. Heme oxygenase 1 mediates anti-inflammatory effects of 2,4,6-tris(methoxymethoxy) chalcone. Eur J Pharmacol 2006 532 178-186
53. Ban H S., Suzuki K, Lim S S., Jung S H., Lee S, Ji J, Lee H S., Lee Y S., Shin K H., Ohuchi K. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase and tumor necrosis factor-alpha by 2-hydroxychalcone derivatives in RAW 264.7 cells. Biochem Pharmacol 2004 67 1549-1557
54. Kim J B., Han A R., Park E Y., Kim J Y., Cho W, Lee J, Seo E K., Lee K T. Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by poncirin through the NF-kappaB inactivation in RAW 264.7 macrophage cells. Biol Pharm Bull 2007 30 2345-2351
55. Sung B, Pandey M K., Aggarwal B B. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation. Mol Pharmacol 2007 71 1703-1714
56. Kunnumakkara A B., Nair A S., Ahn K S., Pandey M K., Yi Z, Liu M, Aggarwal B B. Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-kappaB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis. Blood 2007 109 5112-5121
57. Ju W, Wang X, Shi H, Chen W, Belinsky S A., Lin Y. A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-kappaB pathway and sensitization of apoptosis in lung cancer cells. Mol Pharmacol 2007 71 1381-1388
58. Pan M H., Lai C S., Wang Y J., Ho C T. Acacetin suppressed LPS-induced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice. Biochem Pharmacol 2006 72 1293-1303
59. Shukla S, Gupta S. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes. Clin Cancer Res 2004 10 3169-3178
60. Romier B, Van De Walle J, During A, Larondelle Y, Schneider Y J. Modulation of signalling nuclear factor-kappaB activation pathway by polyphenols in human intestinal Caco-2 cells. Brit J Nutr 2008 100 542-551
61. Cheng P Y., Lee Y M., Wu Y S., Chang T W., Jin J S., Yen M H. Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro. Biochem Pharmacol 2007 73 793-804
62. Nakamura N, Hayasaka S, Zhang X Y., Nagaki Y, Matsumoto M, Hayasaka Y, Terasawa K. Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kappaB binding activities induced by interleukin-1beta in human retinal pigment epithelial cell line. Exp Eye Res 2003 77 195-202
63. Burnett B P., Jia Q, Zhao Y, Levy R M. A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation. J Med Food 2007 10 442-451
64. Li B Q., Fu T, Gong W H., Dunlop N, Kung H, Yan Y, Kang J, Wang J M. The flavonoid baicalin exhibits anti-inflammatory activity by binding to chemokines. Immunopharmacology 2000 49 295-306
65. Aquila S, Giner R M., Recio M C., Spegazzini E D., Rios J L. Anti-inflammatory activity of flavonoids from Cayaponia tayuya roots. J Ethnopharmacol 2009 121 333-337
66. Huang S T., Chen C T., Chieng K T., Huang S H., Chiang B H., Wang L F., Kuo H S., Lin C M. Inhibitory effects of a rice hull constituent on tumor necrosis factor alpha, prostaglandin E2, and cyclooxygenase-2 production in lipopolysaccharide-activated mouse macrophages. Ann NY Acad Sci 2005 1042 387-395
67. Takada Y, Aggarwal B B. Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p65 phosphorylation: abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9. J Biol Chem 2004 279 4750-4759
68. Messmann R A., Ullmann C D., Lahusen T, Kalehua A, Wasfy J, Melillo G, Ding I, Headlee D, Figg W D., Sausville E A., Senderowicz A M. Flavopiridol-related proinflammatory syndrome is associated with induction of interleukin-6. Clin Cancer Res 2003 9 562-570
69. Kim H P., Park H, Son K H., Chang H W., Kang S S. Biochemical pharmacology of biflavonoids: implications for anti-inflammatory action. Arch Pharm Res 2008 31 265-273
70. Suh S J., Jin U H., Kim S H., Chang H W., Son J K., Lee S H., Son K H., Kim C H. Ochnaflavone inhibits TNF-alpha-induced human VSMC proliferation via regulation of cell cycle, ERK1/2, and MMP-9. J Cell Biochem 2006 99 1298-1307
71. Lee K W., Kang N J., Heo Y S., Rogozin E A., Pugliese A, Hwang M K., Bowden G T., Bode A M., Lee H J., Dong Z. Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res 2008 68 946-955
72. Lee K W., Kang N J., Rogozin E A., Kim H G., Cho Y Y., Bode A M., Lee H J., Surh Y J., Bowden G T., Dong Z. Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1. Carcinogenesis 2007 28 1918-1927
73. Muoz-Espada A C., Watkins B A. Cyanidin attenuates PGE2 production and cyclooxygenase-2 expression in LNCaP human prostate cancer cells. J Nutr Biochem 2006 17 589-596
74. Xu W, Liu J, Li C, Wu H Z., Liu Y W. Kaempferol-7- O -beta-D-glucoside (KG) isolated from Smilax china L. rhizome induces G2/M phase arrest and apoptosis on HeLa cells in a p53-independent manner. Cancer Lett 2008 264 229-240
75. Hamalainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007 2007 45673
76. Kim J Y., Jung K J., Choi J S., Chung H Y. Modulation of the age-related nuclear factor-kappaB (NF-kappaB) pathway by hesperetin. Aging Cell 2006 5 401-411
77. Singh R P., Mallikarjuna G U., Sharma G, Dhanalakshmi S, Tyagi A K., Chan D C., Agarwal C, Agarwal R. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance. Clin Cancer Res 2004 10 8641-8647
78. Bito T, Roy S, Sen C K., Shirakawa T, Gotoh A, Ueda M, Ichihashi M, Packer L. Flavonoids differentially regulate IFN gamma-induced ICAM-1 expression in human keratinocytes: molecular mechanisms of action. FEBS Lett 2002 520 145-152
79. Ferrandiz M L., Gil B, Sanz M J., Ubeda A, Erazo S, Gonzlez E, Negrete R, Pacheco S, Pay M, Alcaraz M J. Effect of bakuchiol on leukocyte functions and some inflammatory responses in mice. J Pharm Pharmacol 1996 48 975-980
80. Rajakangas J, Misikangas M, Paivarinta E, Mutanen M. Chemoprevention by white currant is mediated by the reduction of nuclear beta-catenin and NF-kappaB levels in Min mice adenomas. Eur J Nutr 2008 47 115-122
81. Boivin D, Blanchette M, Barrette S, Moghrabi A, Beliveau R. Inhibition of cancer cell proliferation and suppression of TNF-induced activation of NFkappaB by edible berry juice. Anticancer Res 2007 27 937-948
82. Chen P N., Kuo W H., Chiang C L., Chiou H L., Hsieh Y S., Chu S C. Black rice anthocyanins inhibit cancer cells invasion via repressions of MMPs and u-PA expression. Chem Biol Interact 2006 163 218-229
83. Chen P N., Chu S C., Chiou H L., Kuo W H., Chiang C L., Hsieh Y S. Mulberry anthocyanins, cyanidin 3-rutinoside and cyanidin 3-glucoside, exhibited an inhibitory effect on the migration and invasion of a human lung cancer cell line. Cancer Lett 2006 235 248-259
84. Afaq F, Malik A, Syed D, Maes D, Matsui M S., Mukhtar H. Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign. Photochem Photobiol 2005 81 38-45
85. Kang J L., Lee H W., Lee H S., Pack I S., Chong Y, Castranova V, Koh Y. Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. Am J Respir Crit Care Med 2001 164 2206-2212
86. Kang J S., Yoon Y D., Han M H., Han S B., Lee K, Kang M R., Moon E Y., Jeon Y J., Park S K., Kim H M. Estrogen receptor-independent inhibition of tumor necrosis factor-alpha gene expression by phytoestrogen equol is mediated by blocking nuclear factor-kappaB activation in mouse macrophages. Biochem Pharmacol 2005 71 136-143
87. Manna S K., Aggarwal R S., Sethi G, Aggarwal B B., Ramesh G T. Morin (3,5, 7,2,4-pentahydroxyflavone) abolishes nuclear factor-kappaB activation induced by various carcinogens and inflammatory stimuli, leading to suppression of nuclear factor-kappaB-regulated gene expression and up-regulation of apoptosis. Clin Cancer Res 2007 13 2290-2297
88. Tabary O, Escotte S, Couetil J P., Hubert D, Dusser D, Puchelle E, Jacquot J. Relationship between IkappaBalpha deficiency, NFkappaB activity and interleukin-8 production in CF human airway epithelial cells. Pflugers Arch 2001 443 (Suppl.1) S40-S44
89. Kang J S., Yoon Y D., Cho I J., Han M H., Lee C W., Park S K., Kim H M. Glabridin, an isoflavan from licorice root, inhibits inducible nitric-oxide synthase expression and improves survival of mice in experimental model of septic shock. J Pharmacol Exp Ther 2005 312 1187-1194
90. Ahn K S., Noh E J., Cha K H., Kim Y S., Lim S S., Shin K H., Jung S H. Inhibitory effects of irigenin from the rhizomes of Belamcanda chinensis on nitric oxide and prostaglandin E(2) production in murine macrophage RAW 264.7 cells. Life Sci 2006 78 2336-2342
91. De Melo G O., Muzitano M F., Legora-Machado A, Almeida T A., De Oliveira D B., Kaiser C R., Koatz V L., Costa S S. C-glycosylflavones from the aerial parts of Eleusine indica inhibit LPS-induced mouse lung inflammation. Planta Med 2005 71 362-363
92. Chen K H., Weng M S., Lin J K. Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells. Biochem Pharmacol 2007 73 215-227
93. Tuchinda P, Saiai A, Pohmakotr M, Yoosook C, Kasisit J, Napaswat C, Santisuk T, Reutrakul V. Anti-HIV-1 cycloartanes from leaves and twigs of Gardenia thailandica. Planta Med 2004 70 366-370 (Pubitemid 38594611)
94. Lowe S W., Lin A W. Apoptosis in cancer. Carcinogenesis 2000 21 485-495
95. Shishodia S, Aggarwal B B. Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer. Cancer Treat Res 2004 119 139-173
96. Dorn C, Kraus B, Motyl M, Weiss T S., Gehrig M, Schlmerich J, Heilmann J, Hellerbrand C. Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis. Mol Nutr Food Res in press[nl]
97. Harikumar K B., Kunnumakkara A B., Ahn K S., Anand P, Krishnan S, Guha S, Aggarwal B B. Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells. Blood 2009 113 2003-2013
98. Pandey M K., Sung B, Ahn K S., Aggarwal B B. Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1. Mol Pharmacol 2009 75 525-533
99. Wang Y, Chan F L., Chen S, Leung L K. The plant polyphenol butein inhibits testosterone-induced proliferation in breast cancer cells expressing aromatase. Life Sci 2005 77 39-51
100. Hsu Y L., Kuo P L., Chiang L C., Lin C C. Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non-small cell lung cancer a549 cells. Clin Exp Pharmacol Physiol 2004 31 414-418
101. Kanazawa M, Satomi Y, Mizutani Y, Ukimura O, Kawauchi A, Sakai T, Baba M, Okuyama T, Nishino H, Miki T. Isoliquiritigenin inhibits the growth of prostate cancer. Eur Urol 2003 43 580-586
102. Ma J, Fu N Y., Pang D B., Wu W Y., Xu A L. Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells. Planta Med 2001 67 754-757
103. Yamazaki S, Morita T, Endo H, Hamamoto T, Baba M, Joichi Y, Kaneko S, Okada Y, Okuyama T, Nishino H, Tokue A. Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma. Cancer Lett 2002 183 23-30
104. Kimura Y, Taniguchi M, Baba K. Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots. Planta Med 2004 70 211-219
105. Kimura Y, Baba K. Antitumor and antimetastatic activities of Angelica keiskei roots, part 1: isolation of an active substance, xanthoangelol. Int J Cancer 2003 106 429-437
106. Lee Y S., Lim S S., Shin K H., Kim Y S., Ohuchi K, Jung S H. Anti-angiogenic and anti-tumor activities of 2-hydroxy-4-methoxychalcone. Biol Pharm Bull 2006 29 1028-1031
107. Li Z D., Hu X W., Wang Y T., Fang J. Apigenin inhibits proliferation of ovarian cancer A2780 cells through Id1. FEBS Lett 2009 583 1999-2003
108. Franzen C A., Amargo E, Todorovic V, Desai B V., Huda S, Mirzoeva S, Chiu K, Grzybowski B A., Chew T L., Green K J., Pelling J C. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism. Cancer Prev Res (Phila Pa) 2009 2 830-841
109. Hu X W., Meng D, Fang J. Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase. Carcinogenesis 2008 29 2369-2376
110. Lee W J., Chen W K., Wang C J., Lin W L., Tseng T H. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Toxicol Appl Pharmacol 2008 226 178-191
111. Androutsopoulos V P., Mahale S, Arroo R R., Potter G. Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation. Oncol Rep 2009 21 1525-1528
112. Lin Y, Shi R, Wang X, Shen H M. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 2008 8 634-646
113. Wu B, Zhang Q, Shen W, Zhu J. Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line. Mol Cell Biochem 2008 313 125-132
114. Bagli E, Stefaniotou M, Morbidelli L, Ziche M, Psillas K, Murphy C, Fotsis T. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3-kinase activity. Cancer Res 2004 64 7936-7946
115. Zhou Q, Yan B, Hu X, Li X B., Zhang J, Fang J. Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin. Mol Cancer Ther 2009 8 1684-1691
116. Chang H L., Su J H., Yeh Y T., Lee Y C., Chen H M., Wu Y C., Yuan S S. Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo. Cancer Lett 2008 267 85-95
117. Luo G, Guan X, Zhou L. Apoptotic effect of citrus fruit extract nobiletin on lung cancer cell line A549 in vitro and in vivo. Cancer Biol Ther 2008 7 966-973
118. Miyata Y, Sato T, Yano M, Ito A. Activation of protein kinase C betaII/epsilon-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin. Mol Cancer Ther 2004 3 839-847
119. Miyata Y, Sato T, Imada K, Dobashi A, Yano M, Ito A. A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells. Biochem Biophys Res Commun 2008 366 168-173
120. Morley K L., Ferguson P J., Koropatnick J. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Lett 2007 251 168-178
121. Bracke M E., Vyncke B M., Van Larebeke N A., Bruyneel E A., De Bruyne G K., De Pestel G H., De Coster W J., Espeel M F., Mareel M M. The flavonoid tangeretin inhibits invasion of MO4 mouse cells into embryonic chick heart in vitro. Clin Exp Metastasis 1989 7 283-300
122. Murillo G, Hirschelman W H., Ito A, Moriarty R M., Kinghorn A D., Pezzuto J M., Mehta R G. Zapotin, a phytochemical present in a Mexican fruit, prevents colon carcinogenesis. Nutr Cancer 2007 57 28-37
123. Pan M H., Lai C S., Hsu P C., Wang Y J. Acacetin induces apoptosis in human gastric carcinoma cells accompanied by activation of caspase cascades and production of reactive oxygen species. J Agric Food Chem 2005 53 620-630
124. Singh R P., Agrawal P, Yim D, Agarwal C, Agarwal R. Acacetin inhibits cell growth and cell cycle progression, and induces apoptosis in human prostate cancer cells: structure-activity relationship with linarin and linarin acetate. Carcinogenesis 2005 26 845-854
125. Yang S F., Yang W E., Kuo W H., Chang H R., Chu S C., Hsieh Y S. Antimetastatic potentials of flavones on oral cancer cell via an inhibition of matrix-degrading proteases. Arch Oral Biol 2008 53 287-294
126. Arafa el-SA, Zhu Q, Barakat B M., Wani G, Zhao Q, El-Mahdy M A., Wani A A. Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. Cancer Res 2009 69 8910-8917
127. Peng C Y., Pan S L., Huang Y W., Guh J H., Chang Y L., Teng C M. Baicalein attenuates intimal hyperplasia after rat carotid balloon injury through arresting cell-cycle progression and inhibiting ERK, Akt, and NF-kappaB activity in vascular smooth-muscle cells. Naunyn Schmiedebergs Arch Pharmacol 2008 378 579-588
128. Androutsopoulos V P., Ruparelia K, Arroo R R., Tsatsakis A M., Spandidos D A. CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells. Toxicology 2009 264 162-170
129. Du G, Han G, Zhang S, Lin H, Wu X, Wang M, Ji L, Lu L, Yu L, Liang W. Baicalin suppresses lung carcinoma and lung metastasis by SOD mimic and HIF-1alpha inhibition. Eur J Pharmacol 2010 630 121-130
130. Li Y, Bhuiyan M, Alhasan S, Senderowicz A M., Sarkar F H. Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol. Clin Cancer Res 2000 6 223-229
131. Luo H, Rankin G O., Liu L, Daddysman M K., Jiang B H., Chen Y C. Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutr Cancer 2009 61 554-563
132. Li W, Du B, Wang T, Wang S, Zhang J. Kaempferol induces apoptosis in human HCT116 colon cancer cells via the ataxia-telangiectasia mutated-p53 pathway with the involvement of p53upregulated modulator of apoptosis. Chem Biol Interact 2009 177 121-127
133. Chien S Y., Wu Y C., Chung J G., Yang J S., Lu H F., Tsou M F., Wood W, Kuo S J., Chen D R. Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells. Hum Exp Toxicol 2009 28 493-503
134. Tan J, Wang B, Zhu L. Regulation of survivin and Bcl-2 in HepG2 cell apoptosis induced by quercetin. Chem Biodivers 2009 6 1101-1110
135. Shan B E., Wang M X., Li R Q. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest 2009 27 604-612
136. Zhang W, Zhang F. Effects of quercetin on proliferation, apoptosis, adhesion and migration, and invasion of HeLa cells. Eur J Gynaecol Oncol 2009 30 60-64
137. Siegelin M D., Reuss D E., Habel A, Rami A, von Deimling A. Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells. Neuro Oncol 2009 11 122-131
138. Kim E J., Choi C H., Park J Y., Kang S K., Kim Y K. Underlying mechanism of quercetin-induced cell death in human glioma cells. Neurochem Res 2008 33 971-979
139. van der Woude H, Ter Veld M G., Jacobs N, van der Saag P T., Murk A J., Rietjens I M. The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor. Mol Nutr Food Res 2005 49 763-771
140. Amado N G., Cerqueira D M., Menezes F S., da Silva J F., Neto V M., Abreu J G. Isoquercitrin isolated from Hyptis fasciculata reduces glioblastoma cell proliferation and changes beta-catenin cellular localization. Anticancer Drugs 2009 20 543-552
141. Lin J P., Yang J S., Lu C C., Chiang J H., Wu C L., Lin J J., Lin H L., Yang M D., Liu K C., Chiu T H., Chung J G. Rutin inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immune response in vivo. Leuk Res 2009 33 823-828
142. Ali H A., Chowdhury A K., Rahman A K., Borkowski T, Nahar L, Sarker S D. Pachypodol, a flavonol from the leaves of Calycopteris floribunda, inhibits the growth of CaCo-2 colon cancer cell line in vitro. Phytother Res 2008 22 1684-1687
143. van Ginkel P R., Sareen D, Subramanian L, Walker Q, Darjatmoko S R., Lindstrom M J., Kulkarni A, Albert D M., Polans A S. Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res 2007 13 5162-5169
144. Cecchinato V, Chiaramonte R, Nizzardo M, Cristofaro B, Basile A, Sherbet G V., Comi P. Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells. Biochem Pharmacol 2007 74 1568-1574
145. Marel A K., Lizard G, Izard J C., Latruffe N, Delmas D. Inhibitory effects of trans -resveratrol analogs molecules on the proliferation and the cell cycle progression of human colon tumoral cells. Mol Nutr Food Res 2008 52 538-548
146. Roccaro A M., Leleu X, Sacco A, Moreau A S., Hatjiharissi E, Jia X, Xu L, Ciccarelli B, Patterson C J., Ngo H T., Russo D, Vacca A, Dammacco F, Anderson K C., Ghobrial I M., Treon S P. Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenstrom's macroglobulinemia. Clin Cancer Res 2008 14 1849-1858
147. Zhao W, Bao P, Qi H, You H. Resveratrol down-regulates survivin and induces apoptosis in human multidrug-resistant SPC-A-1/CDDP cells. Oncol Rep 2010 23 279-286
148. Schlachterman A, Valle F, Wall K M., Azios N G., Castillo L, Morell L, Washington A V., Cubano L A., Dharmawardhane S F. Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Transl Oncol 2008 1 19-27
149. Castillo-Pichardo L, Martinez-Montemayor M M., Martinez J E., Wall K M., Cubano L A., Dharmawardhane S. Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols. Clin Exp Metastasis 2009 26 505-516
150. De Leo M, Braca A, Sanogo R, Cardile V, DeTommasi N, Russo A. Antiproliferative activity of Pteleopsis suberosa leaf extract and its flavonoid components in human prostate carcinoma cells. Planta Med 2006 72 604-610
151. Lin J, Zhang S M., Wu K, Willett W C., Fuchs C S., Giovannucci E. Flavonoid intake and colorectal cancer risk in men and women. Am J Epidemiol 2006 164 644-651 (Pubitemid 44453493)
152. Ko C H., Shen S C., Lin H Y., Hou W C., Lee W R., Yang L L., Chen Y C. Flavanones structure-related inhibition on TPA-induced tumor promotion through suppression of extracellular signal-regulated protein kinases: involvement of prostaglandin E2 in anti-promotive process. J Cell Physiol 2002 193 93-102
153. Hsiao Y C., Kuo W H., Chen P N., Chang H R., Lin T H., Yang W E., Hsieh Y S., Chu S C. Flavanone and 2-OH flavanone inhibit metastasis of lung cancer cells via down-regulation of proteinases activities and MAPK pathway. Chem Biol Interact 2007 167 193-206
154. Virgili F, Acconcia F, Ambra R, Rinna A, Totta P, Marino M. Nutritional flavonoids modulate estrogen receptor alpha signaling. IUBMB Life 2004 56 145-151
155. Bulzomi P, Bolli A, Galluzzo P, Leone S, Acconcia F, Marino M. Naringenin and 17beta-estradiol coadministration prevents hormone-induced human cancer cell growth. IUBMB Life 2010 62 51-60
156. Totta P, Acconcia F, Leone S, Cardillo I, Marino M. Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor alpha and beta signalling. IUBMB Life 2004 56 491-499
157. Deep G, Singh R P., Agarwal C, Kroll D J., Agarwal R. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin. Oncogene 2006 25 1053-1069
158. Dorta D J., Pigoso A A., Mingatto F E., Rodrigues T, Prado I M., Helena A F., Uyemura S A., Santos A C., Curti C. The interaction of flavonoids with mitochondria: effects on energetic processes. Chem Biol Interact 2005 152 67-78
159. Choi E J., Lee J I., Kim G H. Anti-carcinogenic effect of a new analogue 4-chloroflavanone from flavanone in human breast cancer cells. Int J Mol Med 2010 25 293-298
160. Rho Y H., Lee B W., Park K H., Bae Y S. Cudraflavanone A purified from Cudrania tricuspidata induces apoptotic cell death of human leukemia U937 cells, at least in part, through the inhibition of DNA topoisomerase I and protein kinase C activity. Anticancer Drugs 2007 18 1023-1028
161. He Q, Li R, Fang L, Ying H, Hu Y, Yang B. Antileukemia activity of MSFTZ-a novel flavanone analog. Anticancer Drugs 2006 17 641-647
162. Singletary K W., Stansbury M J., Giusti M, Van Breemen R B., Wallig M, Rimando A. Inhibition of rat mammary tumorigenesis by concord grape juice constituents. J Agric Food Chem 2003 51 7280-7286
163. Cai H, Marczylo T H., Teller N, Brown K, Steward W P., Marko D, Gescher A J. Anthocyanin-rich red grape extract impedes adenoma development in the Apc(Min) mouse: pharmacodynamic changes and anthocyanin levels in the murine biophase. Eur J Cancer 2010 46 811-817
164. Seeram N P., Adams L S., Hardy M L., Heber D. Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J Agric Food Chem 2004 52 2512-2517
165. Olsson M E., Gustavsson K E., Andersson S, Nilsson A, Duan R D. Inhibition of cancer cell proliferation in vitro by fruit and berry extracts and correlations with antioxidant levels. J Agric Food Chem 2004 52 7264-7271
166. Afaq F, Syed D N., Malik A, Hadi N, Sarfaraz S, Kweon M H., Khan N, Zaid M A., Mukhtar H. Delphinidin, an anthocyanidin in pigmented fruits and vegetables, protects human HaCaT keratinocytes and mouse skin against UVB-mediated oxidative stress and apoptosis. J Invest Dermatol 2007 127 222-232
167. Reddivari L, Vanamala J, Chintharlapalli S, Safe S H., Miller Jr J C. Anthocyanin fraction from potato extracts is cytotoxic to prostate cancer cells through activation of caspase-dependent and caspase-independent pathways. Carcinogenesis 2007 28 2227-2235
168. Martin S, Giannone G, Andriantsitohaina R, Martinez M C. Delphinidin, an active compound of red wine, inhibits endothelial cell apoptosis via nitric oxide pathway and regulation of calcium homeostasis. Br J Pharmacol 2003 139 1095-1102
169. Kuo P L., Hsu Y L., Lin T C., Lin C C. The antiproliferative activity of prodelphinidin B-2 3- O -gallate from green tea leaf is through cell cycle arrest and Fas-mediated apoptotic pathway in A549 cells. Food Chem Toxicol 2005 43 315-323
170. Zhang Y, Vareed S K., Nair M G. Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetables. Life Sci 2005 76 1465-1472
171. Shih P H., Yeh C T., Yen G C. Effects of anthocyanidin on the inhibition of proliferation and induction of apoptosis in human gastric adenocarcinoma cells. Food Chem Toxicol 2005 43 1557-1566
172. Wang L S., Hecht S S., Carmella S G., Yu N, Larue B, Henry C, McIntyre C, Rocha C, Lechner J F., Stoner G D. Anthocyanins in black raspberries prevent esophageal tumors in rats. Cancer Prev Res (Phila Pa) 2009 2 84-93
173. Hafeez B B., Siddiqui I A., Asim M, Malik A, Afaq F, Adhami V M., Saleem M, Din M, Mukhtar H. A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling. Cancer Res 2008 68 8564-8572
174. Favot L, Martin S, Keravis T, Andriantsitohaina R, Lugnier C. Involvement of cyclin-dependent pathway in the inhibitory effect of delphinidin on angiogenesis. Cardiovasc Res 2003 59 479-487
175. Huang H P., Shih Y W., Chang Y C., Hung C N., Wang C J. Chemoinhibitory effect of mulberry anthocyanins on melanoma metastasis involved in the Ras/PI3K pathway. J Agric Food Chem 2008 56 9286-9293
176. Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 1995 125 790S-797S
177. Barnes S. The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Res Treat 1997 46 169-179
178. Verma S P., Goldin B R. Effect of soy-derived isoflavonoids on the induced growth of MCF-7 cells by estrogenic environmental chemicals. Nutr Cancer 1998 30 232-239
179. Jung S H., Lee Y S., Lee S, Lim S S., Kim Y S., Ohuchi K, Shin K H. Anti-angiogenic and anti-tumor activities of isoflavonoids from the rhizomes of Belamcanda chinensis. Planta Med 2003 69 617-622
180. Maurich T, Iorio M, Chimenti D, Turchi G. Erybraedin C and bitucarpin A, two structurally related pterocarpans purified from Bituminaria bituminosa, induced apoptosis in human colon adenocarcinoma cell lines MMR- and p53-proficient and -deficient in a dose-, time-, and structure-dependent fashion. Chem Biol Interact 2006 159 104-116
181. Choi H J., Eun J S., Kim B G., Kim S Y., Jeon H, Soh Y. Vitexin, an HIF-1alpha inhibitor, has anti-metastatic potential in PC12 cells. Mol Cells 2006 22 291-299
182. You K M., Son K H., Chang H W., Kang S S., Kim H P. Vitexicarpin, a flavonoid from the fruits of Vitex rotundifolia, inhibits mouse lymphocyte proliferation and growth of cell lines in vitro. Planta Med 1998 64 546-550
183. Clubbs E A., Bomser J A. Basal cell induced differentiation of noncancerous prostate epithelial cells (RWPE-1) by glycitein. Nutr Cancer 2009 61 390-396
184. Clubbs E A., Bomser J A. Glycitein activates extracellular signal-regulated kinase via vascular endothelial growth factor receptor signaling in nontumorigenic (RWPE-1) prostate epithelial cells. J Nutr Biochem 2007 18 525-532
185. Pan M H., Chen W J., Lin-Shiau S Y., Ho C T., Lin J K. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis 2002 23 1677-1684
186. Lichius J J., Thoison O, Montagnac A, Pas M, Guritte-Voegelein F, Svenet T, Cosson J P., Hadi A H. Antimitotic and cytotoxic flavonols from Zieridium pseudobtusifolium and Acronychia porteri. J Nat Products 1994 57 1012-1016
187. Shi Q, Chen K, Li L, Chang J J., Autry C, Kozuka M, Konoshima T, Estes J R., Lin C M., Hamel E. Antitumor agents, 154. Cytotoxic and antimitotic flavonols from Polanisia dodecandra. J Nat Products 1995 58 475-482
188. Dorn C, Weiss T S., Heilmann J, Hellerbrand C. Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells. Int J Oncol 2010 36 435-441
189. Guruvayoorappan C, Kuttan G. Amentoflavone stimulates apoptosis in B16F-10 melanoma cells by regulating bcl-2, p53 as well as caspase-3 genes and regulates the nitric oxide as well as proinflammatory cytokine production in B16F-10 melanoma cells, tumor associated macrophages and peritoneal macrophages. J Exp Ther Oncol 2008 7 207-218
190. Aalinkeel R, Hu Z, Nair B B., Sykes D E., Reynolds J L., Mahajan S D., Schwartz S H. Genomic analysis highlights the role of the JAK-STAT signaling in the anti-proliferative effects of dietary flavonoid 'Ashwagandha' in prostate cancer cells. Evid Based Complement Alternat Med 2010 7 177-187
191. Guruvayoorappan C, Kuttan G. Rutin inhibits nitric oxide and tumor necrosis factor-alpha production in lipopolysaccharide and concanavalin-a stimulated macrophages. Drug Metabol Drug Interact 2007 22 263-278
192. Bandyopadhyay S, Romero J R., Chattopadhyay N. Kaempferol and quercetin stimulate granulocyte-macrophage colony-stimulating factor secretion in human prostate cancer cells. Mol Cell Endocrinol 2008 287 57-64
193. Lee S, Kim Y J., Kwon S, Lee Y, Choi S Y., Park J, Kwon H J. Inhibitory effects of flavonoids on TNF-alpha-induced IL-8 gene expression in HEK 293 cells. BMB Rep 2009 42 265-270
194. Sharma V, Joseph C, Ghosh S, Agarwal A, Mishra M K., Sen E. Kaempferol induces apoptosis in glioblastoma cells through oxidative stress. Mol Cancer Ther 2007 6 2544-2553
195. Liu S, Ma Z, Cai H, Li Q, Rong W, Kawano M. Inhibitory effect of baicalein on IL-6-mediated signaling cascades in human myeloma cells. Eur J Haematol 2009 84 137-144
196. Chittezhath M, Deep G, Singh R P., Agarwal C, Agarwal R. Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells. Mol Cancer Ther 2008 7 1817-1826
197. Cortes J R., Perez G M., Rivas M D., Zamorano J. Kaempferol inhibits IL-4-induced STAT6 activation by specifically targeting JAK3. J Immunol 2007 179 3881-3887
198. Shchemelinin I, Sefc L, Necas E. Protein kinases, their function and implication in cancer and other diseases. Folia Biol (Praha) 2006 52 81-100
199. Fabbro D, Ruetz S, Buchdunger E, Cowan-Jacob S W., Fendrich G, Liebetanz J, Mestan J, O'Reilly T, Traxler P, Chaudhuri B, Fretz H, Zimmermann J, Meyer T, Caravatti G, Furet P, Manley P W. Protein kinases as targets for anticancer agents: from inhibitors to useful drugs. Pharmacol Ther 2002 93 79-98
200. Teillet F, Boumendjel A, Boutonnat J, Ronot X. Flavonoids as RTK inhibitors and potential anticancer agents. Med Res Rev 2008 28 715-745
201. Zhang J, Yang P L., Gray N S. Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 2009 9 28-39
202. Schroeter H, Boyd C, Spencer J P., Williams R J., Cadenas E, Rice-Evans C. MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiol Aging 2002 23 861-880
203. Virgili F, Marino M. Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity. Free Radic Biol Med 2008 45 1205-1216
204. Williams R J., Spencer J P., Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 2004 36 838-849
205. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Rmsy C, Chap H, Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 1997 53 1649-1657
206. Matter W F., Brown R F., Vlahos C J. The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem Biophys Res Commun 1992 186 624-631
207. Spencer J P., Rice-Evans C, Williams R J. Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem 2003 278 34783-34793
208. Gamet-Payrastre L, Manenti S, Gratacap M P., Tulliez J, Chap H, Payrastre B. Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol 1999 32 279-286 (Pubitemid 29146039)
209. Kong A N., Yu R, Chen C, Mandlekar S, Primiano T. Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch Pharm Res 2000 23 1-16
210. Kumamoto T, Fujii M, Hou D X. Myricetin directly targets JAK1 to inhibit cell transformation. Cancer Lett 2009 275 17-26
211. Jung S K., Lee K W., Byun S, Kang N J., Lim S H., Heo Y S., Bode A M., Bowden G T., Lee H J., Dong Z. Myricetin suppresses UVB-induced skin cancer by targeting Fyn. Cancer Res 2008 68 6021-6029
212. Kim J E., Kwon J Y., Lee D E., Kang N J., Heo Y S., Lee K W., Lee H J. MKK4 is a novel target for the inhibition of tumor necrosis factor-alpha-induced vascular endothelial growth factor expression by myricetin. Biochem Pharmacol 2009 77 412-421
213. He Z, Tang F, Ermakova S, Li M, Zhao Q, Cho Y Y., Ma W Y., Choi H S., Bode A M., Yang C S., Dong Z. Fyn is a novel target of ()-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation. Mol Carcinogen 2008 47 172-183
214. Walker E H., Pacold M E., Perisic O, Stephens L, Hawkins P T., Wymann M P., Williams R L. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 2000 6 909-919
215. Kang N J., Lee K W., Rogozin E A., Cho Y Y., Heo Y S., Bode A M., Lee H J., Dong Z. Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway. J Biol Chem 2007 282 32856-32866